322 results
8-K
ACUR
Acura Pharmaceuticals, Inc
4 Jun 24
Departure of Directors or Certain Officers
11:00am
. Clemens’s retirement, the Board has approved or ratified the following actions.
Although Mr. Clemens will remain an employee of the Company as Vice
8-K
ACUR
Acura Pharmaceuticals, Inc
26 May 23
Entry into a Material Definitive Agreement
8:30am
such amount is paid in full.
The funding provided by AD Pharma, along with the $235,000 received in May 2023 under the employee retention credit (“ERC
S-8
EX-10.1
4oelnjvmzuk3y
1 Jun 21
Registration of securities for employees
4:10pm
S-8
4zzkzu4fswcgevu
1 Jun 21
Registration of securities for employees
4:10pm
8-K
EX-10.1
a2lljo
27 May 21
Departure of Directors or Certain Officers
4:11pm